Group items matching

in title, tags, annotations or url

The clinical decision support systems market is projected to reach USD 1,752.0 Million by 2023 from USD 901.0 Million in 2017, at a CAGR of 11.8%. Factors such as government support & initiatives, growing incidence of medication errors, rising prominence & usage of big data and mhealth tools, high returns on investment for CDSS solutions, and growing adoption of cloud computing in healthcare are driving the growth of this market.

Premature ejaculation is a condition of losing the ability to control and maintain ejaculation reflexes in men when having sexual activity, thereby causing ejaculation even though it is not time to ejaculate, the consequences will create frustration, disappointment for one or both men and women. This problem can affect the happiness and happiness of both and is often called "not going to the market has run out of money". This pathology needs to be treated to fix it on a case-by-case basis. Premature ejaculation may be due to psychological and physical causes. In terms of psychological causes, in order to have a normal sexual intercourse between men and women at Men's Health Clinic, there must be a smooth balance between the excitement and inhibition processes; when excessive excitement can lead to premature ejaculation; In fact, masturbation in long-term men can form a reflex of conditional premature ejaculation, which in turn leads to premature ejaculation during actual sexual intercourse. Regarding the entity, there are many different causes such as: there is an increased sensitivity of the penis, pelvic inflammatory diseases, some endocrine disorders including hypogonadism, male sexual abstinence, increased blood prolactin ... Men's Health Clinic in Viet Nam can affect the function of penis erection and ejaculation function; There is also the hypothesis that serotonin receptors increase susceptibility, serotonin receptor hypersensitivity include 5-HT2C (5-hydroxytryptamine receptor 2C) receptors and 5-HT1A (5-hydroxytryptamine receptors). 1A) in the central nervous system can lead to premature ejaculation that has been accepted by many scientists. Source: Men's Health Clinic Viet Nam First, we have to ask about the disease that is acquired because the diagnosis of premature ejaculation is mainly based on the question. Questions can be divided into groups such as: Questions for diagnosis are set about how long ejaculation takes? Intravaginal ejaculation latency t

Three pharmacists have collectively acquired Leyton Green, a community pharmacy on the outskirts of London Borough, as its owner, Raj Baxi, opts to retire after 15 years of service. The pharmacy, which processes an average of 2,697 items per month, was recently sold for an undisclosed sum, said Christie & Co, who facilitated the confidential transaction. The trio, led by Abdus Subhan, intends to drive the business forward by expanding the range of items and introducing advanced services. "After nearly 15 years in Walthamstow, we will miss our loyal customers, but we are pleased for the pharmacy to go to experienced operators," Baxi said.

Novartis on Wednesday (February 1) predicted that core operating income would grow in a "mid single digit" percentage range in 2023 following stagnation last year, as the Swiss drugmaker prepares to spin off its Sandoz generics business. Full-year core operating income was broadly flat at $16.7 billion, it said in a statement, coming in slightly below market expectations of $16.8 billion. Adjusted for overall negative currency effects, group sales in 2022 advanced 4 per cent to $50.5 billion as gains from heart failure drug Entresto and multiple sclerosis (MS) drug Kesimpta were partly offset by competition from cheap generic copies of established MS drug Gilenya. Novartis said it was on track to spin off its generics unit Sandoz in the second half of the year as part of its effort to sharpen its focus on its patented prescription medicines. Analysts have welcomed a programme unveiled in 2022 to trim costs and cut 8,000 jobs and plans to focus on fewer therapy areas and drug technologies. But the market has been underwhelmed by prospects for medium-term growth from new drugs.

In partnership with the pharmaceutical company Boehringer Ingelheim, Leeds Teaching Hospitals Trust (LTHT) has recently established an innovative cardiometabolic clinic. The clinic focuses on reducing cardiovascular risk in people with diabetes who have recently been discharged from LTHT following a heart attack. It is delivered jointly by the cardiology department at Leeds General Infirmary and the diabetes services at the Trust. This is a patient-centred approach to reducing that risk, with pharmacist-delivered clinics scheduled for six to eight weeks after the heart attack. Stephen Wheatcroft, Professor of Cardiometabolic Medicine and Consultant Cardiologist at LTHT, said: "This is an exciting and innovative development, one of the first in the country. Previously, Type 2 diabetic patients presenting with heart issues would have been treated by two separate specialty teams. This is the first time there has been a specific clinic combining the cardiac and diabetes team working together. "We aim to reduce the risk for patients, with earlier multidisciplinary hospital care, to help discharged patients achieve better diabetes control, through improved medication support and optimisation, reducing the need for further treatment and future hospital stays. Overall, it will mean a better patient experience, with improved monitoring and information about treatment options, along with a reduction in waiting times for review in a specialist clinic."

The Department of Health and Social Care (DHSC) has finally published its response to the 2022 consultation on hub and spoke dispensing. Considering the consultation evidence and further discussions, the government has expressed its intention to progress the proposals for enabling hub and spoke models across different legal entities as soon as possible. This will be achieved by using the enabling powers outlined in Part 2 of the Medicines and Medical Devices Act 2021 (MMDA) to amend the Medicines Act 1968 and the HMRs. Furthermore, the DHSC has decided to proceed with the implementation of the two models of hub and spoke dispensing that it consulted on. The government response to the consultation reads: "Having considered the responses, the government intend to proceed to implement the necessary changes to medicines legislation to remove the current restrictions that prevent the hub and spoke dispensing models from operating across different legal entities found in section 10 of the Medicines Act 1968.

The National Pharmacy Association (NPA) has raised concerns over the upcoming increase in the National Living Wage, saying it will make things even worse for local pharmacies already facing nearly a decade of cuts in real terms. Scheduled to go up from £10.42 to £11.44 per hour starting April, the National Living Wage rise is expected to put a lot of financial pressure on many pharmacies. The NPA says "it will cost them over £10,000 in salary bills, and for some, even more, without getting more from the NHS funds. and has asked the government to deal with the ongoing problem of underfunding for community pharmacies. The association has warned that without additional funds, pharmacies could face staff layoffs or reduced services to cover the increased wages, calling for a "comprehensive new funding deal to prevent further closures of vital local services, which have been shutting at the rate of eight a week."

What initially began as two close friends taking a leisurely walk to escape their everyday routine has evolved into a meaningful endeavour to support the fight against cancer. Jamie Sparrow, Senior Vice President - Commercial, EMENA at Accord Healthcare, and Jamie Durbidge, Owner & Managing Director of Perennial Pharma, will be undertaking a 5-day walking challenge to support The Luke Hart Foundation in raising funds for Cancer Research UK. The two Jamies have been friends for more than 15 years and worked together at Mylan, now Viatris, where Jamie S served as Managing Director, while Jamie D held the position of Sales Director for some years. During the COVID pandemic when everybody was stuck at home, the two friends, both early risers, used to spend hours in the mornings walking and talking over the phone, about anything and everything - work, life, family, the Pharmaceutical Industry, politics, sport, and about challenges that people were having during the lockdown. After continuing this routine for several months, they eventually planned to transform their daily ritual into a "walking and talking" trip to reconnect, catch up on things, and enjoy some time together and with friends who wanted to join them.